Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2012 Oct 15;109(44):18108–18113. doi: 10.1073/pnas.1206723109

Central amygdala nucleus (Ce) gene expression linked to increased trait-like Ce metabolism and anxious temperament in young primates

Andrew S Fox a,b,c,1, Jonathan A Oler b,d, Steven E Shelton b,d, Steven A Nanda d, Richard J Davidson a,b,c,d, Patrick H Roseboom d, Ned H Kalin a,b,c,d,1
PMCID: PMC3497741  PMID: 23071305

Abstract

Children with anxious temperament (AT) are particularly sensitive to new social experiences and have increased risk for developing anxiety and depression. The young rhesus monkey is optimal for studying the origin of human AT because it shares with humans the genetic, neural, and phenotypic underpinnings of complex social and emotional functioning. In vivo imaging in young monkeys demonstrated that central nucleus of the amygdala (Ce) metabolism is relatively stable across development and predicts AT. Transcriptome-wide gene expression, which reflects combined genetic and environmental influences, was assessed within the Ce. Results support a maladaptive neurodevelopmental hypothesis linking decreased amygdala neuroplasticity to early-life dispositional anxiety. For example, high AT individuals had decreased mRNA expression of neurotrophic tyrosine kinase, receptor, type 3 (NTRK3). Moreover, variation in Ce NTRK3 expression was inversely correlated with Ce metabolism and other AT-substrates. These data suggest that altered amygdala neuroplasticity may play a role the early dispositional risk to develop anxiety and depression.

Keywords: positron-emission tomography, microarray, brain imaging


The ability to identify brain mechanisms underlying the risk during childhood for developing anxiety and depression is critical for establishing novel early-life interventions aimed at preventing the chronic and debilitating outcomes associated with these common illnesses. To this end, we have optimized a model of anxious temperament (AT), the conserved at-risk phenotype, in young developing rhesus monkeys (14). The rhesus monkey is ideal for studying the origin of human AT because these species share the genetic, neural, and phenotypic underpinnings of complex social and emotional functioning (510). Importantly, the rhesus developmental model bridges the critical gap between human psychopathology and rodent models, allowing for translation to humans by using in vivo imaging measures and translation to rodents by using ex vivo molecular methods. Thus, the unique hypotheses that can be generated from the rhesus model are invaluable in guiding both imaging studies in children and mechanistic efforts in rodents.

Of particular relevance to the AT rhesus model is the relatively recent evolutionary divergence between rhesus monkeys and humans (25 million years) compared with rodents and humans (70 million years) (5). This evolutionary closeness is reflected in the species’ similarities in social and emotional behaviors. These homologies, instantiated in their conserved genetic and neural systems, underlie the ability of both humans and rhesus monkeys to form and maintain the relationships necessary for living in complex social environments. In this regard, the experience of anxiety has evolved in primates to motivate the formation of long-lasting attachment bonds that serve to increase security and group cohesion. The comparable rearing practices shared by these species (e.g., close mother–infant bonding) promote early social/emotional learning, which serves to adaptively regulate anxiety and promote survival (7).

Although periods of marked anxiety and fear are common during early childhood, most children overcome these anxieties through learning associated with experience and maturation. As they develop, typical children learn to discern real threats from distorted fears and, in concert, effectively regulate their behavior to adaptively cope. However, a subset of children with extreme AT do not develop this capacity, maintaining a stable anxious disposition that confers increased risk for the development of anxiety and mood disorders (1113). AT begins as early shyness and is later characterized by chronic anxiety, negative affect, and worry (14). AT is also associated with increased activity of stress-sensitive peripheral systems, including increased pituitary–adrenal tone and heightened sympathetic activity (11).

Because early social-emotional learning is critical for the adaptive regulation of anxiety, we have been especially interested in processes demonstrated to underlie learning during development. Furthermore, recent preclinical and clinical research has identified neurotrophic factors (15) and other neuroplastic processes as critical for overcoming adult psychopathology (1618). Therefore, we hypothesized that altered neurotrophic processes in the young brain would lead to the emergence and maintenance of childhood AT. In particular, we theorize that deficits in the ability to modify the connections and composition of AT’s neural substrate could result in a failure to learn how to adaptively regulate anxiety, which can manifest as a tendency to generalize perceptions of threat to neutral stimuli. Because AT can be identified early in life, characterizing the biological factors that promote the maintenance of stable AT can potentially lead to targeted early-life interventions aimed at decreasing the risk for developing psychopathology.

Similar to anxious children, young monkeys with high levels of AT are those that show increased freezing, decreased vocalizations, and increased cortisol when exposed to the no-eye contact condition (NEC) of the human-intruder paradigm, an ethologically relevant mild social threat. Our studies demonstrated that, like human AT, monkey AT is trait-like and heritable (19). Using functional brain imaging in conjunction with ex vivo molecular analyses of relevant brain regions, the monkey model allows for the longitudinal study of AT and its underlying neural substrates. With functional brain imaging, we identified the central nucleus of the amygdala (Ce) and anterior hippocampus as components of the neural circuit underlying AT (2, 19). Moreover, we found that young primates with high AT have increased metabolism in these regions when studied in both stressful and nonstressful contexts (2). These data set the stage for in-depth molecular studies in primates focused on understanding the mechanisms mediating the function of the brain regions underlying AT.

The Ce is of interest because its efferent projections coordinate autonomic, hormonal, behavioral, and emotional responses to stress (20), and Ce lesions in monkeys are sufficient to reduce AT (21). Furthermore, rodent studies demonstrate that direct Ce manipulations markedly alter unconditioned anxiety responses (22), similar to those elicited by novel or potentially threatening situations in children with high AT. The prefrontal cortex and other amygdala nuclei primarily influence fear and anxiety-related responding via the Ce, where intra-Ce microcircuits play a critical role dynamically gating these inputs (2326). Recent work in rhesus monkeys demonstrates that, unlike most amygdala nuclei, the Ce continues to mature from the first year of life into early adulthood (27). This protracted developmental period suggests that Ce maturation may be particularly susceptible to environmental influences. A causal relation between social group size and dorsal amygdala volume demonstrates the importance of social influences on the primate amygdala (28). These findings are consistent with our data highlighting the importance of environmental contributions to Ce metabolism as it relates to early-life AT (19). For these reasons, we selected the Ce for in depth molecular analyses, with a particular focus on processes within the Ce that underlie learning. Although learning-related research has generally focused on the hippocampus (e.g., refs. 29 and 30) and basal/lateral amygdala regions (31), recent rodent studies highlight the role of plasticity and emotional learning in the Ce (32, 33). In addition to its role in anxiety, the Ce has recently been linked to habit formation (34) and, at a cellular and neurochemical level, it has much in common with the striatum (35), a structure known to mediate the development of long-term ingrained response patterns (36). Although Ce microcircuits are ideally suited to perform the childhood learning that results in adaptive anxiety, when Ce learning is disrupted, it could result in trait-like habitual fear and anxiety responding.

Building on our finding that individual differences in Ce metabolism predict AT, we performed mRNA expression studies in Ce tissue collected from young monkeys repeatedly phenotyped for AT and its associated brain metabolism. This unique, multilevel approach combines the power of functional brain imaging with the potential of gene expression studies to characterize the mRNAs that could underlie the risk for developing anxiety and depression. We hypothesized that high-AT individuals would have alterations in mRNAs within the Ce that reflect the influences of experience on the persistent expression of anxiety. Specifically, we predicted a role for mRNAs encoding molecules with the potential to facilitate habitual anxiety and developmentally appropriate adaptive fear learning. Such alterations are of particular interest, because manipulations of these substrates could result in treatments for high-AT children that would facilitate their ability to modify and adaptively regulate their anxiety.

Accordingly, a subset of 24 animals was selected from 238 rhesus monkeys that were initially characterized for behavior and brain metabolism. The 238 monkeys were injected with [18F]-fluoro-2-deoxyglucose (FDG) and exposed for 30 min to the NEC condition that elicits the AT phenotype (19). During NEC, a human (“the intruder”) enters the test room and presents her profile to the monkey, avoiding eye contact (1). Following NEC exposure, animals were anesthetized, and high-resolution positron-emission tomography (PET) scans were performed to examine the integrated brain metabolism that occurred during the preceding 30-min NEC exposure. FDG-PET is optimal for simultaneously assessing sustained neural activity and natural behavior in unconstrained individuals because FDG is taken up into metabolically active cells over the course of ∼30 min and remains trapped for the duration of its ∼110-min half-life. This extended assessment of brain metabolism is ideal for studying the neural underpinnings of AT, which are sustained over time.

Results and Discussion

The subset of 24 males underwent further testing to characterize the trait-like components of AT and its neural substrate across development [Fig. 1A; animals noted in pink constituted the subset that was further tested; age at first assessment: mean, 2.1 (range, 0.85–3.5 y); age at last assessment: mean, 3.2 (range, 1.8–4.2)]. The age span of this sample is similar to childhood through early adolescence in humans because 1-y-old monkeys are similar to 3- to 4-y-old children, and male monkeys enter adolescence around 3–4 y of age. The 24 monkeys were phenotyped for brain and behavior on two additional occasions, 6–18 mo after their initial assessment. Between the second and third assessment, half of the animals were relocated every 5 d over a period of 3 wk. Relocation did not have any significant effects on behavior or physiology (SI Methods). To examine the stability of AT, we tested the interrelations among the three repeated measurements, controlling for relocation, age, and interval between assessments. Relations among the AT measures were significant [time 1 to time 2: t = 6.83, P < 0.0001; time 1 to time 3: t = 3.80, P = 0.001; time 2 to time 3: t = 5.16, P < 0.0001; accounting for between 44% and 72% of the variance in AT across time points and corresponding to an interclass correlation coefficient (ICC)3,1 = 0.72], confirming AT’s relative stability over this developmental period.

Fig. 1.

Fig. 1.

Stable amygdala metabolism predicts dispositional AT. (A) In a large cohort of monkeys (n = 238), we identified regions in which metabolic activity predicted AT [yellow; see Oler et al. (19)]. In yellow is the anterior temporal lobe cluster, which encompasses the Ce region (red) most predictive of AT. As can be seen in the regression plot, 24 animals (pink dots) were selected to represent the full range of variability in AT and Ce metabolism. (B) Longitudinal assessments of brain metabolism in the 24 animals demonstrate that portions of the temporal lobe clusters are stable over time (purple) [FDR-corrected within AT-related regions defined by Oler et al. (19) (yellow) for three pairwise stability tests, i.e., T1-T2, T2-T3, T1-T3]. (C) Mean longitudinal assessments of brain metabolism and AT were significantly correlated (pink) within the region where metabolism was stable (FDR-corrected within the purple region of stability from B). (D) Scatterplot depicting relations between metabolism within the amygdala region (pink) depicted in C and mean AT residualized for relocation, age and interval between assessments (r = 0.47; P = 0.0377).

We hypothesized that the stability of AT would be reflected by similar consistency in the function of its neural substrates. Therefore, we intercorrelated the three measures of NEC-induced brain metabolism in the regions predictive of AT, controlling for relocation, age, and interval between assessments. AT-predictive regions were defined from our previous study and included bilateral anterior temporal lobe clusters, bilateral occipital lobe clusters, and a midline parietal lobe cluster (19). Results demonstrated relative stability as denoted by significant interrelations among the three NEC-induced metabolism measurements within each of these clusters [corrected for multiple comparisons using false discovery rate (FDR); q < 0.05 FDR across maps in AT-related regions, with voxel-wise ICC3,1 coefficients ranging from 0.30 to 0.70 (median, 0.57); Fig. 1B and Table S1]. Voxels within every cluster we tested, including dorsal and ventral regions of amygdala, anterior portions of hippocampus, superior temporal sulcus (STS), agranular insula, temporal and insular proisocortices, claustrum, visual cortex, and precuneus, demonstrated significantly stable NEC-induced metabolism. These data demonstrate that individual differences in metabolism within the neural circuit underlying AT are relatively stable across juvenile development.

We next examined covariation between the stable components of AT and its neural substrates. For each animal, the stable components of AT and regional brain metabolism were estimated by computing their means across each of the three longitudinal assessments. Mean AT was regressed against mean voxel-wise metabolism in significantly stable AT-related regions, while controlling for relocation, age, the interval between scans, and voxel-wise gray matter probability (GMP). Results demonstrated that mean metabolism in amygdalar regions (including Ce and the basolateral complex), anterior hippocampus, and visual cortex predicted mean AT (q < 0.05 FDR in stable AT-related regions; Fig. 1 C and D and Table S2). To confirm involvement of the Ce within the larger amygdalar cluster we assessed the overlap between this cluster and a map of in vivo serotonin transporter binding derived from separate animals (37). Precise localization of the Ce can be determined with this method because this amygdalar nucleus has the highest density of serotonin transporter binding compared with neighboring structures (38) (SI Methods). Results confirmed that mean metabolism in the Ce region predicted mean AT across assessments. This longitudinal assessment of brain and behavior extends prior work characterizing the neural substrates of AT by demonstrating that the trait-like nature of AT is reflected in trait-like metabolism within the Ce and other AT-related brain regions.

To characterize the molecular underpinnings of AT and its neural substrate, animals were killed and brain tissue was collected for assessment of gene expression. Because of our interest in the trait-like nature of AT and its context-independent brain metabolism, we collected brain tissue from animals in their baseline state, 4–5 d following final NEC exposure. In contrast to studies of stimulus-evoked gene expression, this approach allows for optimal characterization of temperament-related transcripts. mRNA was extracted from the Ce region most predictive of AT (n = 238; Figs. 1A and 2). mRNA expression levels were assessed using the Affymetrix Rhesus Monkey microarray (SI Methods). Brain samples collected were counterbalanced for hemisphere because bilateral Ce metabolism was associated with AT. To quantify the association between dispositional AT and Ce mRNA levels, mean AT was correlated with mRNA expression levels. Microarray data were analyzed using bioconductor (39) for microarray analysis in R (see SI Methods for details). Microarray data were preprocessed using robust multichip average (RMA) background correction, constant normalized across chips, and summarized across probes using the median-polish technique (40). Resulting gene expression levels were visually inspected using MA plots (Fig. S1). Gene expression was also assessed using Plier background correction and quantile normalization to verify that gene distribution patterns did not arise from specific preprocessing techniques (i.e., Plier and quantile normalization). Robust regression analyses between mean AT- and RMA-determined mRNA levels (controlling for relocation, biopsy hemisphere, and age) were performed on annotated transcripts (http://www.unmc.edu/rhesusgenechip/) that had at least moderate expression levels [>log2(100)]. Covarying for age ensures that significant AT-related transcripts, although assessed during development, are not reflective of age-related changes. The empirical Bayes method was used to determine levels of significance and the FDR was used to account for multiple comparisons.

Fig. 2.

Fig. 2.

Stable Ce regions predictive of dispositional AT were used to guide amygdala biopsy. (AC) Brains from the 24 animals were sectioned into 4.5-mm coronal slabs centered on the functionally defined amygdala region (∼0.9 mm [orange] to ∼5.4 mm [cyan], posterior to anterior commissure), shown as a 3D rendering (A), a 2D slice through the functionally defined amygdala region (B), and a representative single-subject slab with amygdala biopsy site (magenta arrow) (C). (D) The biopsied region corresponds to the location of Ce (pink), as shown in the series of atlas slices [adapted with permission (69)]. Slices are arranged from anterior (orange) to posterior (cyan).

Results revealed 139 RMA-determined transcripts that predicted AT (FDR q < 0.05, two-tailed; Table S3; to demonstrate these correlations are not attributable to the normalization technique, Table S3 also includes the correlations between AT and Plier background corrected and quantile normalized transcripts). Consistent with the concept that multiple systems underlie stress-related psychopathology, both manual inspection and gene-ontology enrichment analyses revealed that the 139 FDR-corrected AT-related transcripts reflect diverse biological systems (SI Methods and Table S4). Within the Biological Processes ontology, 35 significantly overrepresented terms were identified. Three of these terms are of particular interest in relation to our maladaptive neurodevelopmental hypothesis of AT. These include response to hormone stimulus (GO:0009725) and related terms, positive regulation of axon extension (GO:0045773), and positive regulation of developmental growth (GO:0048639). Of note, the neurotrophic tyrosine kinase, receptor, type 3 (NTRK3) and the leucine-rich repeat protein ISLR2 (Ig superfamily containing leucine-rich repeat 2; also known as Linx) are the only constituents from the FDR corrected list of 139 genes that are represented across all 3 terms. Because multiple comparison correction of AT-related transcripts likely results in false negatives and the possibility that the exclusion of these genes can alter ontology term representation, we also performed gene-ontology enrichment analyses on significantly (P < 0.05) uncorrected AT-related genes. Although not identical, the results support the inferences of the FDR-corrected ontology analyses (Table S5). Significantly overrepresented terms included regulation of axon regeneration (GO:0048679) and cell morphogenesis (GO:0000902), both of which included NTRK3. Although future research would benefit from exploring other significantly AT-related genes and overrepresented ontology terms, because of our theoretical interest in the mechanisms of Ce-learning during development, we focused our analyses on NTKR3 and related transcripts. Quantitative real-time PCR (qRT-PCR) was performed on select transcripts including NTRK3, IRS2, and ISLR2 (P values, <0.05) to confirm the relations between gene expression and AT.

NTRK3 and insulin receptor substrate 2 (IRS2) are of particular interest because their activation by the endogenous growth factor neurotrophin-3 (NTF-3) can initiate synaptogenesis and neurogenesis (41, 42) (Fig. 3). The NTRK3 gene encodes a membrane-bound receptor that phosphorylates intracellular transducers, including IRS2 (43). The downstream influences of IRS2 can manifest via activation of the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathway (44). AKT signaling affects synaptic plasticity, axonal development, amygdala-dependent learning, and behavioral responses to stress (45, 46). Additionally, ISLR2 sits on the cell membrane, aids in the guiding of axons, and can facilitate the activation of trk receptors, including NTRK3 (47, 48). In addition to its involvement in our theoretically motivated focus on neuroplasticity, NTRK3 genetic variation has been linked to human psychopathology, including childhood-onset mood disorders (4952), and via its extracellular domain may provide an accessible drug target. Taken together, these findings implicate NTRK3 as a prominent target for future mechanistic studies examining childhood AT.

Fig. 3.

Fig. 3.

Ce expression of the neurotrophic receptor NTRK3 predicts AT. (A) Schematic of the pathway for NTRK3, a neuroplasticity-associated molecule (green). Microarray data showed that individuals with higher levels of Ce NTRK3 mRNA expression exhibited lower AT. A similar pattern was found for a downstream target of NTRK3, IRS2 (yellow). Other molecules in the NTRK3 pathway are depicted in gray. (B) qRT-PCR confirmed the negative relationship between Ce NTRK3 mRNA expression levels and AT, controlling for relocation, biopsy hemisphere, and age (r = 0.49; P = 0.029).

Using the prospectively acquired trait-like measures of brain metabolism, we investigated the neural systems by which altered Ce NTRK3 expression influences AT. A voxel-wise search, controlling for age, hemisphere of biopsy, relocation, and GMP, was performed to identify AT-related brain regions in which Ce NTRK3 mRNA levels predicted mean metabolic activity. Results demonstrated significant negative relationships between Ce NTRK3 expression and glucose metabolism within the right amygdala (including the Ce region) and anterior hippocampus, as well as significant positive relations within visual cortex (Fig. 4; FDR q < 0.05 in stable AT-predictive regions; Table S6). Although the left Ce region did not survive multiple comparison correction, the relationship between NTRK3 expression and left Ce metabolism was significant at an uncorrected P = 0.02, which was not significantly weaker than the relationship between NTRK3 expression and right Ce metabolism (t = 0.86; P = 0.40) (53). These primate data combine the use of brain imaging and microarray technology in the same animals and suggest that Ce NTRK3 is a key molecular mediator of AT via its influences on the neural circuit underlying AT.

Fig. 4.

Fig. 4.

NTRK3 is expressed in Ce and negatively predicts Ce metabolism. (A) Acetylcholinesterase (AChE) stain (Left) was used to definitively identify Ce in the brain of one subject. In situ hybridization of NTRK3 was performed on an adjacent slice from the same subject (Right). Magnified insets (Center) reveal that the AChE-defined Ce (dashed-pink) expresses NTRK3 mRNA. (B) Individuals showing higher levels of NTRK3 mRNA expression, indexed by qRT-PCR, show reduced Ce metabolism in vivo (green) [FDR-corrected within the stable AT-related region (pink)].

To examine the unique relation between Ce NTRK3 expression and AT, we assessed motor cortex NTRK3 mRNA. Results demonstrated that motor cortex NTRK3 mRNA levels were unrelated to Ce NTRK3 mRNA levels (t = 0.09; P = 0.928). Moreover, motor cortex NTRK3 mRNA levels were not related to AT (t = 0.24; P = 0.812) nor metabolism in AT-related regions (no significant results at FDR q < 0.05). Although motor cortex metabolism was highly predictive of levels of locomotion (P < 0.05, Sidak-corrected; SI Methods and Table S7), motor cortex NTRK3 mRNA expression was not significantly correlated with either locomotion (t = −1.31; P = 0.190) or motor cortex metabolism (no significant results at FDR q < 0.05; SI Methods). These findings demonstrate that regional NTRK3 mRNA expression is not a general marker for brain metabolism nor is it a nonspecific reflection of behaviors dependent on the region in which NTRK3 mRNA is assessed (e.g., locomotion for motor cortex). This further underscores the specificity of Ce NTRK3 in relation to AT and highlights the importance of site-specific, differential regulation of the NTRK3 gene.

Our results highlight the role of NTRK3 in AT during development but do not implicate NTRK3 mechanistically. Rather, these findings provide an initial rationale for exploring behavioral or pharmacological interventions aimed at up-regulating regional NTRK3 expression early in the lives of individuals likely to develop anxiety and depressive disorders. Recent studies in rodents demonstrate the feasibility of performing early targeted interventions that have long-term impacts on anxiety and adaptive responses to stress (5456). For example, neonatal injections of the neuroplasticity-related growth factor fibroblast growth factor 2 (FGF2) altered the developmental trajectory of high-anxious rodents, resulting in decreased adult anxiety (55). Importantly, early-life FGF2 treatment also enhanced adult neurogenesis, which was accompanied by increased hippocampal expression of NTRK3 (55). Moreover, primate research has demonstrated that neurodevelopmentally relevant gene expression in the amygdala is altered by prolonged maternal separation (57). Taken together, these data are consistent with our demonstration that monkeys with lower levels of AT show greater Ce expression of NTRK3 and further motivate mechanistic research into the role for neurodevelopmentally important transcripts in the development of AT.

Although we focus on NTRK3, it is important to clarify that other genes are also of interest. For example, in addition to its importance in neurotrophic signaling, the involvement of IRS2, which is also critical for insulin signaling, is interesting in its own right. Because of its multiple functions, regulation of IRS2 may be important in the linkages between stress, psychopathology, and the development of associated physiological alterations such as metabolic syndrome and type 2 diabetes. In the periphery, IRS2 regulates insulin sensitivity and in the brain IRS2 impacts multiple functions including reward (58), memory (59, 60), and energy homeostasis (61, 62). Moreover, type 2 diabetes has been associated with amygdala atrophy (63), and bidirectional associations between insulin resistance and affective disorders have been reported (6466). The possibility that altered IRS2 function may play a role in the associations between insulin-related disorders and alterations in stress-related psychopathology via its effects on the amygdala is intriguing. Of particular interest to stress and AT, alterations in cortisol could be important in modulating IRS2 function because the synthetic glucocorticoid dexamethasone prevents phosphorylation of IRS2 (67, 68).

Recent work demonstrating the ongoing development of the primate Ce suggests this nucleus to be particularly susceptible to environmental influences throughout childhood and adolescence (19, 27). Early in childhood, as young children first extend beyond their parents’ reach, they must approach novelty with trepidation. By way of experience and maturation, most children learn to regulate their anxieties and see the world as an opportunity for exploration. This experience-dependent learning results in refined discrimination between threatening and nonthreatening stimuli and likely involves sculpting of intra-Ce connections that dynamically gate the sensory and prefrontal triggers of fear. We hypothesize that decreased capacity for learning and modification within the Ce microcircuit could explain why some children fail to regulate their anxieties and develop an extreme anxious temperament. The findings presented here begin to link specific experience-dependent molecular pathways within the Ce to chronically elevated Ce metabolism and extreme temperamental anxiety. Although there are likely many mediators of AT, these gene expression data are consistent with a maladaptive neurodevelopmental hypothesis as a basis for AT. Future work should aim to extend these data in support of a molecular-neuroscientific rationale for conceptualizing new treatment strategies aimed at normalizing Ce function in vulnerable children before the development of the detrimental behavioral, emotional, and brain sequelae associated with the long-term consequences of chronic anxiety and depression.

Methods

Twenty-four male rhesus monkeys were selected from subjects used by Oler et al. (19) to undergo longitudinal AT and FDG-PET assessments during exposure to potential threat (NEC). Brain tissue was biopsied from the Ce region most predictive of AT, and transcriptome wide RNA expression levels were assessed using Affymetrix GeneChip Rhesus Macaque Genome arrays. All preprocessing and statistical analyses were performed using standard methods. See SI Methods for a detailed description of the procedures used.

Supplementary Material

Supporting Information

Acknowledgments

We thank the staff at the Wisconsin National Primate Center, the Harlow Center for Biological Psychology, the HealthEmotions Research Institute, and The Waisman Laboratory for Brain Imaging and Behavior for facilitating our research. We also thank A. Shackman, A. Alexander, B. Christian, L. Ahlers, A. Converse, T. Oakes, H. Van Valkenberg, K. Myer, J. Spears, E. Larson, and D. French for their technical and analytic assistance in running subjects and analyzing data. This work was supported by National Institutes of Health (NIH) Grants MH91550, MH046729, MH081884, MH084051, HD008352, and HD003352; NIH Training Grant MH018931; the Wisconsin National Primate Research Center (through NIH Grants P51OD011106 and P51RR000167); and the HealthEmotions Research Institute.

Footnotes

The authors declare no conflict of interest.

This article is a PNAS Direct Submission.

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1206723109/-/DCSupplemental.

References

  • 1.Kalin NH, Shelton SE. Defensive behaviors in infant rhesus monkeys: Environmental cues and neurochemical regulation. Science. 1989;243:1718–1721. doi: 10.1126/science.2564702. [DOI] [PubMed] [Google Scholar]
  • 2.Fox AS, Shelton SE, Oakes TR, Davidson RJ, Kalin NH. Trait-like brain activity during adolescence predicts anxious temperament in primates. PLoS ONE. 2008;3:e2570. doi: 10.1371/journal.pone.0002570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Fox AS, et al. Calling for help is independently modulated by brain systems underlying goal-directed behavior and threat perception. Proc Natl Acad Sci USA. 2005;102:4176–4179. doi: 10.1073/pnas.0409470102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kalin NH, Shelton SE, Fox AS, Oakes TR, Davidson RJ. Brain regions associated with the expression and contextual regulation of anxiety in primates. Biol Psychiatry. 2005;58:796–804. doi: 10.1016/j.biopsych.2005.05.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gibbs RA, et al. Rhesus Macaque Genome Sequencing and Analysis Consortium Evolutionary and biomedical insights from the rhesus macaque genome. Science. 2007;316:222–234. doi: 10.1126/science.1139247. [DOI] [PubMed] [Google Scholar]
  • 6.Kalin NH, Shelton SE. Nonhuman primate models to study anxiety, emotion regulation, and psychopathology. Ann N Y Acad Sci. 2003;1008:189–200. doi: 10.1196/annals.1301.021. [DOI] [PubMed] [Google Scholar]
  • 7.Harlow HF. The nature of love. Am Psychol. 1958;13:673–685. [Google Scholar]
  • 8.Adolphs R. What does the amygdala contribute to social cognition? Ann N Y Acad Sci. 2010;1191:42–61. doi: 10.1111/j.1749-6632.2010.05445.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wallis JD. Cross-species studies of orbitofrontal cortex and value-based decision-making. Nat Neurosci. 2012;15:13–19. doi: 10.1038/nn.2956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chareyron LJ, Banta Lavenex P, Amaral DG, Lavenex P. Stereological analysis of the rat and monkey amygdala. J Comp Neurol. 2011;519:3218–3239. doi: 10.1002/cne.22677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Fox NA, Henderson HA, Marshall PJ, Nichols KE, Ghera MM. Behavioral inhibition: Linking biology and behavior within a developmental framework. Annu Rev Psychol. 2005;56:235–262. doi: 10.1146/annurev.psych.55.090902.141532. [DOI] [PubMed] [Google Scholar]
  • 12.Biederman J, et al. Further evidence of association between behavioral inhibition and social anxiety in children. Am J Psychiatry. 2001;158:1673–1679. doi: 10.1176/appi.ajp.158.10.1673. [DOI] [PubMed] [Google Scholar]
  • 13.Essex MJ, Klein MH, Slattery MJ, Goldsmith HH, Kalin NH. Early risk factors and developmental pathways to chronic high inhibition and social anxiety disorder in adolescence. Am J Psychiatry. 2010;167:40–46. doi: 10.1176/appi.ajp.2009.07010051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kagan J, Reznick JS, Snidman N. Biological bases of childhood shyness. Science. 1988;240:167–171. doi: 10.1126/science.3353713. [DOI] [PubMed] [Google Scholar]
  • 15.Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007;10:1089–1093. doi: 10.1038/nn1971. [DOI] [PubMed] [Google Scholar]
  • 16.Krystal JH, et al. Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia. Drug Discov Today. 2009;14:690–697. doi: 10.1016/j.drudis.2009.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Manji HK, Moore GJ, Rajkowska G, Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry. 2000;5:578–593. doi: 10.1038/sj.mp.4000811. [DOI] [PubMed] [Google Scholar]
  • 18.Pittenger C, Duman RS. Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology. 2008;33:88–109. doi: 10.1038/sj.npp.1301574. [DOI] [PubMed] [Google Scholar]
  • 19.Oler JA, et al. Amygdalar and hippocampal substrates of anxious temperament differ in their heritability. Nature. 2010;466:864–868. doi: 10.1038/nature09282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Davis M, Whalen PJ. The amygdala: Vigilance and emotion. Mol Psychiatry. 2001;6:13–34. doi: 10.1038/sj.mp.4000812. [DOI] [PubMed] [Google Scholar]
  • 21.Kalin NH, Shelton SE, Davidson RJ. The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate. J Neurosci. 2004;24:5506–5515. doi: 10.1523/JNEUROSCI.0292-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Tye KM, et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature. 2011;471:358–362. doi: 10.1038/nature09820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ehrlich I, et al. Amygdala inhibitory circuits and the control of fear memory. Neuron. 2009;62:757–771. doi: 10.1016/j.neuron.2009.05.026. [DOI] [PubMed] [Google Scholar]
  • 24.Ciocchi S, et al. Encoding of conditioned fear in central amygdala inhibitory circuits. Nature. 2010;468:277–282. doi: 10.1038/nature09559. [DOI] [PubMed] [Google Scholar]
  • 25.Haubensak W, et al. Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature. 2010;468:270–276. doi: 10.1038/nature09553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Pare D, Duvarci S. 2012. Amygdala microcircuits mediating fear expression and extinction. Curr Opin Neurobiol 22:717–723.
  • 27.Chareyron LJ, Lavenex PB, Amaral DG, Lavenex P. Postnatal development of the amygdala: A stereological study in macaque monkeys. J Comp Neurol. 2012;520:1965–1984. doi: 10.1002/cne.23023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Sallet J, et al. Social network size affects neural circuits in macaques. Science. 2011;334:697–700. doi: 10.1126/science.1210027. [DOI] [PubMed] [Google Scholar]
  • 29.Kim JJ, Diamond DM. The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci. 2002;3:453–462. doi: 10.1038/nrn849. [DOI] [PubMed] [Google Scholar]
  • 30.Ming G-L, Song H. Adult neurogenesis in the mammalian brain: Significant answers and significant questions. Neuron. 2011;70:687–702. doi: 10.1016/j.neuron.2011.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Fanselow MS, LeDoux JE. Why we think plasticity underlying Pavlovian fear conditioning occurs in the basolateral amygdala. Neuron. 1999;23:229–232. doi: 10.1016/s0896-6273(00)80775-8. [DOI] [PubMed] [Google Scholar]
  • 32.Paré D, Quirk GJ, Ledoux JE. New vistas on amygdala networks in conditioned fear. J Neurophysiol. 2004;92:1–9. doi: 10.1152/jn.00153.2004. [DOI] [PubMed] [Google Scholar]
  • 33.Samson RD, Duvarci S, Paré D. Synaptic plasticity in the central nucleus of the amygdala. Rev Neurosci. 2005;16:287–302. doi: 10.1515/revneuro.2005.16.4.287. [DOI] [PubMed] [Google Scholar]
  • 34.Lingawi NW, Balleine BW. Amygdala central nucleus interacts with dorsolateral striatum to regulate the acquisition of habits. J Neurosci. 2012;32:1073–1081. doi: 10.1523/JNEUROSCI.4806-11.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Swanson LW, Petrovich GD. What is the amygdala? Trends Neurosci. 1998;21:323–331. doi: 10.1016/s0166-2236(98)01265-x. [DOI] [PubMed] [Google Scholar]
  • 36.Packard MG, Knowlton BJ. Learning and memory functions of the Basal Ganglia. Annu Rev Neurosci. 2002;25:563–593. doi: 10.1146/annurev.neuro.25.112701.142937. [DOI] [PubMed] [Google Scholar]
  • 37.Christian BT, et al. Serotonin transporter binding and genotype in the nonhuman primate brain using [C-11]DASB PET. Neuroimage. 2009;47:1230–1236. doi: 10.1016/j.neuroimage.2009.05.090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.O’Rourke H, Fudge JL. Distribution of serotonin transporter labeled fibers in amygdaloid subregions: Implications for mood disorders. Biol Psychiatry. 2006;60:479–490. doi: 10.1016/j.biopsych.2005.09.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gentleman RC, et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80. doi: 10.1186/gb-2004-5-10-r80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gautier L, Cope L, Bolstad BM, Irizarry RA. affy—analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20:307–315. doi: 10.1093/bioinformatics/btg405. [DOI] [PubMed] [Google Scholar]
  • 41.Lamballe F, Klein R, Barbacid M. trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell. 1991;66:967–979. doi: 10.1016/0092-8674(91)90442-2. [DOI] [PubMed] [Google Scholar]
  • 42.Duman CH, Duman RS. 2005. Neurobiology and treatment of anxiety: Signal transduction and neural plasticity. Handb Exp Pharmacol 169:305–334.
  • 43.Yamada M, et al. Insulin receptor substrate (IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with phosphatidylinositol 3-kinase in response to brain-derived neurotrophic factor in cultured cerebral cortical neurons. J Biol Chem. 1997;272:30334–30339. doi: 10.1074/jbc.272.48.30334. [DOI] [PubMed] [Google Scholar]
  • 44.van der Heide LP, Ramakers GMJ, Smidt MP. Insulin signaling in the central nervous system: Learning to survive. Prog Neurobiol. 2006;79:205–221. doi: 10.1016/j.pneurobio.2006.06.003. [DOI] [PubMed] [Google Scholar]
  • 45.Lin CH, et al. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron. 2001;31:841–851. doi: 10.1016/s0896-6273(01)00433-0. [DOI] [PubMed] [Google Scholar]
  • 46.Ou L-C, Gean P-W. Regulation of amygdala-dependent learning by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol-3-kinase. Neuropsychopharmacology. 2006;31:287–296. doi: 10.1038/sj.npp.1300830. [DOI] [PubMed] [Google Scholar]
  • 47.Mandai K, et al. LIG family receptor tyrosine kinase-associated proteins modulate growth factor signals during neural development. Neuron. 2009;63:614–627. doi: 10.1016/j.neuron.2009.07.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.de Wit J, Hong W, Luo L, Ghosh A. Role of leucine-rich repeat proteins in the development and function of neural circuits. Annu Rev Cell Dev Biol. 2011;27:697–729. doi: 10.1146/annurev-cellbio-092910-154111. [DOI] [PubMed] [Google Scholar]
  • 49.Feng Y, et al. International Consortium for Childhood-Onset Mood Disorders Association of the neurotrophic tyrosine kinase receptor 3 (NTRK3) gene and childhood-onset mood disorders. Am J Psychiatry. 2008;165:610–616. doi: 10.1176/appi.ajp.2007.07050805. [DOI] [PubMed] [Google Scholar]
  • 50.Armengol L, et al. 5′ UTR-region SNP in the NTRK3 gene is associated with panic disorder. Mol Psychiatry. 2002;7:928–930. doi: 10.1038/sj.mp.4001134. [DOI] [PubMed] [Google Scholar]
  • 51.Alonso P, et al. Genetic susceptibility to obsessive-compulsive hoarding: The contribution of neurotrophic tyrosine kinase receptor type 3 gene. Genes Brain Behav. 2008;7:778–785. doi: 10.1111/j.1601-183X.2008.00418.x. [DOI] [PubMed] [Google Scholar]
  • 52.Athanasiu L, et al. Intron 12 in NTRK3 is associated with bipolar disorder. Psychiatry Res. 2011;185:358–362. doi: 10.1016/j.psychres.2010.05.011. [DOI] [PubMed] [Google Scholar]
  • 53.Williams EJ. The Comparison of Regression Variables. J R Stat Soc Series B. 1959;21:396–399. [Google Scholar]
  • 54.Zhang T-Y, Parent C, Weaver I, Meaney MJ. Maternal programming of individual differences in defensive responses in the rat. Ann N Y Acad Sci. 2004;1032:85–103. doi: 10.1196/annals.1314.007. [DOI] [PubMed] [Google Scholar]
  • 55.Turner CA, Clinton SM, Thompson RC, Watson SJ, Jr, Akil H. Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals. Proc Natl Acad Sci USA. 2011;108:8021–8025. doi: 10.1073/pnas.1103732108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Upton KJ, Sullivan RM. Defining age limits of the sensitive period for attachment learning in rat pups. Dev Psychobiol. 2010;52:453–464. doi: 10.1002/dev.20448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Sabatini MJ, et al. Amygdala gene expression correlates of social behavior in monkeys experiencing maternal separation. J Neurosci. 2007;27:3295–3304. doi: 10.1523/JNEUROSCI.4765-06.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Russo SJ, et al. IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci. 2007;10:93–99. doi: 10.1038/nn1812. [DOI] [PubMed] [Google Scholar]
  • 59.Irvine EE, et al. Insulin receptor substrate 2 is a negative regulator of memory formation. Learn Mem. 2011;18:375–383. doi: 10.1101/lm.2111311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Martín ED, et al. IRS-2 Deficiency impairs NMDA receptor-dependent long-term potentiation. Cereb Cortex. 2012;22:1717–1727. doi: 10.1093/cercor/bhr216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.White MF. Insulin signaling in health and disease. Science. 2003;302:1710–1711. doi: 10.1126/science.1092952. [DOI] [PubMed] [Google Scholar]
  • 62.Taguchi A, Wartschow LM, White MF. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science. 2007;317:369–372. doi: 10.1126/science.1142179. [DOI] [PubMed] [Google Scholar]
  • 63.den Heijer T, et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia. 2003;46:1604–1610. doi: 10.1007/s00125-003-1235-0. [DOI] [PubMed] [Google Scholar]
  • 64.Li C, et al. Diabetes and anxiety in US adults: Findings from the 2006 Behavioral Risk Factor Surveillance System. Diabet Med. 2008;25:878–881. doi: 10.1111/j.1464-5491.2008.02477.x. [DOI] [PubMed] [Google Scholar]
  • 65.Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care. 1997;20:585–590. doi: 10.2337/diacare.20.4.585. [DOI] [PubMed] [Google Scholar]
  • 66.Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care. 2001;24:1069–1078. doi: 10.2337/diacare.24.6.1069. [DOI] [PubMed] [Google Scholar]
  • 67.Caperuto LC, et al. Distinct regulation of IRS proteins in adipose tissue from obese aged and dexamethasone-treated rats. Endocrine. 2006;29:391–398. doi: 10.1385/ENDO:29:3:391. [DOI] [PubMed] [Google Scholar]
  • 68.Rojas FA, Hirata AE, Saad MJA. Regulation of insulin receptor substrate-2 tyrosine phosphorylation in animal models of insulin resistance. Endocrine. 2003;21:115–122. doi: 10.1385/ENDO:21:2:115. [DOI] [PubMed] [Google Scholar]
  • 69.Paxinos G. The Rhesus Monkey Brain in Stereotaxic Coordinates. Amsterdam, Boston, London: Academic; 2009. 2nd Ed. Copyright Academic Press (2009) [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information
1206723109_sd01.xlsx (37.8KB, xlsx)
1206723109_sd02.xlsx (39.2KB, xlsx)
1206723109_sd03.xlsx (65.5KB, xlsx)
1206723109_sd04.xlsx (48.5KB, xlsx)
1206723109_sd05.xlsx (64KB, xlsx)
1206723109_sd06.xlsx (35.2KB, xlsx)
1206723109_sd07.xlsx (39KB, xlsx)

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES